Books about Gleevec from Amazon.com

In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading." Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing.This book was created for medical professionals, students, and members of the general public who want to conduct medical research using the most advanced tools available and spending the least amount of time doing so..
Price: $28.66 [Notify me when price goes down.]

This digital document is an article from Journal of Drugs in Dermatology, published by Thomson Gale on March 1, 2006. The length of the article is 3312 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Imatinib mesylate and dermatology Part 2: a review of the cutaneous side effects of imatinib mesylate.
Author: Noah Scheinfeld
Publication:Journal of Drugs in Dermatology (Magazine/Journal)
Date: March 1, 2006
Publisher: Thomson Gale
Volume: 5 Issue: 3 Page: 228(4)

Distributed by Thomson Gale.
Price: $5.95 [Notify me when price goes down.]

This digital document is an article from Medical Update, published by Benjamin Franklin Literary & Medical Society, Inc. on July 1, 2001. The length of the article is 313 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: REVOLUTIONARY CANCER TREATMENT.(Gleevec)
Publication:Medical Update (Newsletter)
Date: July 1, 2001
Publisher: Benjamin Franklin Literary & Medical Society, Inc.
Volume: 25 Issue: 1 Page: 3

Distributed by Thomson Gale.
Price: $5.95 [Notify me when price goes down.]

This digital document is an article from Internal Medicine News, published by International Medical News Group on February 1, 2003. The length of the article is 842 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Imatinib beats interferon for first-line initial CML therapy. (Chronic Myeloid Leukemia).(chronic myeloid leukemia)
Author: Mitchel L. Zoler
Publication:Internal Medicine News (Magazine/Journal)
Date: February 1, 2003
Publisher: International Medical News Group
Volume: 36 Issue: 3 Page: 45(1)

Article Type: Product/Service Evaluation

Distributed by Thomson Gale.
Price: $5.95 [Notify me when price goes down.]

This digital document is an article from MedSurg Nursing, published by Jannetti Publications, Inc. on December 1, 2002. The length of the article is 2799 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Gleevec[R]: zeroing in on cancer. .
Author: Teri Capriotti
Publication:MedSurg Nursing (Refereed)
Date: December 1, 2002
Publisher: Jannetti Publications, Inc.
Volume: 11 Issue: 6 Page: 301(4)

Distributed by Thomson Gale.
Price: $5.95 [Notify me when price goes down.]

This digital document is an article from Internal Medicine News, published by International Medical News Group on July 15, 2002. The length of the article is 497 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Gleevec beats interferon for initial CML therapy. (Open-Label Phase III Trial).(chronic myeloid leukemia)
Author: Sharon Worcester
Publication:Internal Medicine News (Magazine/Journal)
Date: July 15, 2002
Publisher: International Medical News Group
Volume: 35 Issue: 14 Page: 25(1)

Article Type: Product/Service Evaluation

Distributed by Thomson Gale.
Price: $5.95 [Notify me when price goes down.]

This digital document is an article from Skin & Allergy News, published by Thomson Gale on October 1, 2007. The length of the article is 680 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Gleevec may be effective for mucosal melanomas.(Cutaneous Oncology)
Author: Erik Goldman
Publication:Skin & Allergy News (Magazine/Journal)
Date: October 1, 2007
Publisher: Thomson Gale
Volume: 38 Issue: 10 Page: 21(1)

Distributed by Thomson Gale.
Price: $9.95 [Notify me when price goes down.]

This digital document is an article from Journal of Drugs in Dermatology, published by Thomson Gale on February 1, 2006. The length of the article is 4970 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Part 1 of a 2 part article: a comprehensive review of imatinib mesylate (Gleevec) for dermatological diseases.
Author: Noah Schienfeld
Publication:Journal of Drugs in Dermatology (Magazine/Journal)
Date: February 1, 2006
Publisher: Thomson Gale
Volume: 5 Issue: 2 Page: 117(6)

Distributed by Thomson Gale.
Price: $5.95 [Notify me when price goes down.]